#ap01
Latest news and interesting information about ap01.
Morgan Stanley Initiates Avalyn Pharma with Overweight
Morgan Stanley initiates Avalyn Pharma with Overweight rating and $53 target. The inhaled therapies AP01 and AP02 show promise in pulmonary fibrosis.
Jefferies Initiates Avalyn Pharma with Buy
Jefferies initiates Avalyn Pharma with Buy rating and $52 price target. AP01 shows promising efficacy in progressive lung diseases.
...